tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $11.07. This is a potential upside of $5.73 (107.3%) from yesterday's end of day stock price of $5.34.
Rain Therapeutics's activity chart (see below) currently has 35 price targets and 33 ratings on display.
Analysts average stock forecasts to be materialized ratio is 22.86% with an average time for these price targets to be met of 125.86 days.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Sep-2023. First documented stock forecast 18-May-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1
$-4.26 (-80.99%)
$1.5
2 years 1 months 17 days ago
(18-Sep-2023)
2/6 (33.33%)
$0.16 (19.05%)
309
Hold
$1
$-4.26 (-80.99%)
$17
2 years 4 months 30 days ago
(05-Jun-2023)
1/5 (20%)
$-0.25 (-20.00%)
73
Hold
2 years 5 months 2 days ago
(02-Jun-2023)
2/3 (66.67%)
$10.01 (111.35%)
90
Hold
$1.75
$-3.51 (-66.73%)
$12
2 years 5 months 12 days ago
(23-May-2023)
2/5 (40%)
$0.51 (41.13%)
409
Hold
$17
2 years 5 months 12 days ago
(23-May-2023)
0/1 (0%)
$13.56 (394.19%)
What is RAIN (Rain Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RAIN (Rain Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RAIN (Rain Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RAIN (Rain Therapeutics)?
Which analyst is the currently most bullish on RAIN (Rain Therapeutics)?
Which analyst is the currently most reserved on RAIN (Rain Therapeutics)?
